case_images: PMC9884432_01
case_images: Clinical manifestations of CMC. (A) Facial lesions before treatment, with visible red plaques covered with thick brown scabs. (B) After 1 month of itraconazole treatment, the thick scabs had disappeared, and the plaque area was reduced and flattened.
case_images: CCID-16-231-g0001.jpg
case_images: PMC9884432_01_CCID-16-231-g0001.jpg
case_images: f0001
case_images: A dermatological examination revealed a scattered distribution of erythema and papules on the face, covered with yellow scabs, and the skin lesions around the mouth, nose, and right cheek showed granulomatous hyperplastic plaques, covered with crust-like thick brown scars, which could not be easily removed (Figure 1).
case_images: Microbiological examination of CMC. (A) CHROMagar chromogenic medium showed green colonies, which were uplifted, moist, smooth, and pearly. (B) The drug sensitivity test identified sensitivity to itraconazole, nystatin, and 5-fluorocytosine and moderate sensitivity to terbinafine.
case_images: CCID-16-231-g0002.jpg
case_images: PMC9884432_01_CCID-16-231-g0002.jpg
case_images: f0002
case_images: A chromogenic CHROMagar Candida culture showed a green colony (Figure 2A). The antifungal susceptibility test indicated sensitivity to itraconazole and nystatin and moderate sensitivity to terbinafine (Figure 2B).